{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:15:59Z","timestamp":1761894959286},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.thromres.2009.07.004","type":"journal-article","created":{"date-parts":[[2009,8,24]],"date-time":"2009-08-24T08:08:35Z","timestamp":1251101315000},"page":"614-618","source":"Crossref","is-referenced-by-count":23,"title":["Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome"],"prefix":"10.1016","volume":"124","author":[{"given":"Dolors","family":"T\u00e0ssies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merce","family":"Roqu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Monteagudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Martorell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Sionis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dabit","family":"Arzamendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Heras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan-Carles","family":"Reverter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2009.07.004_bib1","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2009.07.004_bib2","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198512193132501","article-title":"Increased plasma levels of a rapid inhibitor of tissue plasminogen activator inhibitor in young survivors of myocardial infarction","volume":"313","author":"Hamsten","year":"1985","journal-title":"N Eng J Med"},{"key":"10.1016\/j.thromres.2009.07.004_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.atherosclerosis.2007.05.028","article-title":"Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress","volume":"196","author":"Undas","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2009.07.004_bib4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ahj.2007.09.015","article-title":"Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?","volume":"154","author":"Itakura","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2009.07.004_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-0037-1614029","article-title":"Plasma procarboxipeptidase U in men with symptomatic coronary artery disease","volume":"84","author":"Silveira","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.07.004_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0037-1613604","article-title":"Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris","volume":"90","author":"Brouwers","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.07.004_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.ATV.11.1.183","article-title":"Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity","volume":"11","author":"Dawson","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.thromres.2009.07.004_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1055\/s-0037-1615394","article-title":"Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms","volume":"80","author":"Zhao","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.07.004_bib9","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1182\/blood.V98.6.1992","article-title":"A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels","volume":"98","author":"Brouwers","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2009.07.004_bib10","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood.V97.7.2053","article-title":"Identification of polymorphisms in the promoter and the 3\u2032 region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled","volume":"97","author":"Henry","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2009.07.004_bib11","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.ATV.0000074145.58172.BD","article-title":"Development of a genotipe 325-specific proCPU\/TAFI ELISA","volume":"23","author":"Gils","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2009.07.004_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2009.07.004_bib13","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/1529-0131(200010)43:10<2349::AID-ANR24>3.0.CO;2-J","article-title":"The 4G\/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene and thrombosis in patients with the antiphospholipid syndrome","volume":"43","author":"T\u00e0ssies","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.thromres.2009.07.004_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg777","article-title":"Patterns of linkage disequilibrium in the human genome","volume":"3","author":"Ardlie","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.thromres.2009.07.004_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1469-1809.1955.tb01348.x","article-title":"On estimating the relation between blood group and disease","volume":"19","author":"Woolf","year":"1955","journal-title":"Ann Human Genet"},{"key":"10.1016\/j.thromres.2009.07.004_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2009.07.004_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-134-3-200102060-00014","article-title":"Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences","volume":"134","author":"Rauch","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2009.07.004_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/01.ATV.0000015445.22243.F4","article-title":"Plasma Thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe","volume":"22","author":"Juhan-Vague","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2009.07.004_bib19","first-page":"880","article-title":"Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level","volume":"89","author":"Santamar\u00eda","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2009.07.004_bib20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0037-1613387","article-title":"Association between TAFI antigen and Ala147Thr polymorphism of the TAFI gene and the angina pectoris incidence. The PRIME Study (Prospective Epidemiological Study of MI)","volume":"89","author":"Morange","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.07.004_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1160\/TH07-11-0659","article-title":"Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels","volume":"100","author":"Folkeringa","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.07.004_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.thromres.2005.10.006","article-title":"TAFI activity and antigen plasma levels are not increased in acute coronary artery disease patients admitted to a coronary care unit","volume":"118","author":"Cellai","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2009.07.004_bib23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2141.2004.04824.x","article-title":"Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays","volume":"124","author":"Guimar\u00e3es","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2009.07.004_bib24","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1538-7836.2005.01486.x","article-title":"TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME study","volume":"3","author":"Morange","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.07.004_bib25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1074\/jbc.M104444200","article-title":"Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme","volume":"277","author":"Schneider","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2009.07.004_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clinbiochem.2006.10.020","article-title":"Curiouser and curiouser: Recent advances in measurement of thrombin activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles","volume":"40","author":"Boffa","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.thromres.2009.07.004_bib27","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1160\/TH03-05-0308","article-title":"Thrombin activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis","volume":"90","author":"Lau","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.07.004_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2004.06.003","article-title":"Thr325Ile polymorphism of the TAFI gene is related to TAFI antigen plasma levels and angiographic restenosis after percutaneous coronary interventions","volume":"114","author":"Segev","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2009.07.004_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1538-7836.2008.03221.x","article-title":"Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study","volume":"7","author":"Tregouet","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.07.004_bib30","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/ATVBAHA.107.149468","article-title":"Association of plasminogen activator inhibitor (PAI)-1 (serpine1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters. The HIFMECH study","volume":"27","author":"Morange","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2009.07.004_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11239-007-0083-z","article-title":"Plasminogen activator inhibitor-1 4G\/4G genotype is associated with myocardial infarction but not with stable coronary artery disease","volume":"26","author":"Onalan","year":"2008","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2009.07.004_bib32","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1160\/TH06-12-0745","article-title":"Association between the plasminogen activator inhibitor-1 4G\/5G polymorphism and venous thrombosis. A meta-analysis","volume":"97","author":"Tsantes","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.07.004_bib33","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1160\/TH07-04-0301","article-title":"The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions","volume":"98","author":"Pons","year":"2007","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938480900320X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938480900320X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T04:16:54Z","timestamp":1558498614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938480900320X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S004938480900320X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2009.07.004","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}